Fumie Kobayashi
15Patents
7h-index
25Co-inventors
58Inventor score
Filing activity: Feb 26, 1996 → Aug 31, 2004
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6919434B1 | Monoclonal antibodies that bind OCIF | Emerging Cross-Sectional Technologies | 53 | Expired |
| US6855808B2 | Proteins and methods for producing the proteins | Human Necessities | 15 | Expired |
| US7125686B1 | Proteins and methods for producing the proteins | Human Necessities | 11 | Expired |
| US7468268B2 | Nucleic acid molecules encoding osteoclastogenesis inhibitory factor proteins | Human Necessities | 10 | Expired |
| US7276344B2 | Methods for using the osteoclastogenesis inhibitory factor (OCIF) protein | Human Necessities | 10 | Expired |
| US7205397B2 | Proteins and methods for producing the proteins | Human Necessities | 10 | Expired |
| US7449185B2 | Antibodies to OCIF-binding molecules | Physics | 8 | Expired |
| US7527790B2 | Methods of reducing bone absorption comprising administering an antibody that binds OBM | Physics | 7 | Expired |
| US7192718B2 | Methods for identifying a substance which specifically binds to an osteoclastogenesis inhibitory factor-binding molecule and modulates the biological activity thereof | Physics | 7 | Expired |
| US6046033A | Basic osteoblast growth factor II (bOGF-II) | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6693175B2 | Method for diagnosing bone dysbolism | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6306827A | Method for preventing and/or treating renal disease | Human Necessities | 4 | Expired |
| US7252973B1 | Protein and processes for producing the same | Human Necessities | 1 | Expired |
| US6998242B2 | Method of diagnosing metabolic bone diseases | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6399744B1 | TCF mutant | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.